Fort Point Capital Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Fort Point Capital Partners’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-520	Closed	-$125K	–	115
2017 Q1	$125K	Buy	520 +6	+1%	+$1.61K	0.06%	104
2016 Q4	$142K	Buy	514 +14	+3%	+$3.33K	0.08%	101
2016 Q3	$111K	Buy	500 +95	+23%	+$26.6K	0.05%	136
2016 Q2	$157K	Sell	405 -3	-0.7%	-$3.28K	0.08%	112
2016 Q1	$275K	Buy	408 +99	+32%	+$66.7K	0.14%	86
2015 Q4	$324K	Buy	+309	New	+$306K	0.16%	79

Other funds holding AMPE

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NFG

Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Fort Point Capital Partners's AMPE Position: Q2 2017 in Review

Fort Point Capital Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2017, closing a stake of 520 shares — an estimated $125K sold.

Fort Point Capital Partners first reported a position in AMPE in Q4 2015 and held it in 6 quarters. The position peaked at $324K in Q4 2015. 56 funds tracked by Wall St. Rank hold AMPE as of Q2 2017.

Fort Point Capital Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2017 after selling out during the quarter.
Fort Point Capital Partners sold 520 Ampio Pharmaceuticals Inc. shares in Q2 2017, an estimated $125K.
Fort Point Capital Partners first reported a position in Ampio Pharmaceuticals Inc. in Q4 2015 and held it in 6 quarters.
Fort Point Capital Partners's Ampio Pharmaceuticals Inc. position peaked at $324K in Q4 2015.
56 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2017.

Based on Fort Point Capital Partners's 13F filing for Q2 2017, filed 14 Aug 2017.